Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Aethlon Medical to Present the Aethlon ADAPTâ„¢ System at C21 BioVenturesâ„¢ Life Sciences Partnering Conference

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 23, 2011 / PRNewswire / -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present the Aethlon ADAPT™ system in a...

Your Wireless Healthcare Provided By PulseOximetersPlus

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., May 23, 2011 /- The healthcare and computing industries rely heavily on mobility. For the past decade, the healthcare industry has been adopting new technologies allowing medical professionals and patients to be more mobile. New medical devices strive to meet these...

CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

ATLANTA, May 23, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that its founder and CEO, Jay Yadav, M.D., was presented with a...

Advertisement

FDA approves Incivek for hepatitis C

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., May 23, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for...

Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compar...

May 23, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Wash., May 23, 2011 /- Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 18-month data from its Phase 2 CUPID clinical trial of MYDICAR® demonstrated continued...

Isis Pharmaceuticals to Present a General Corporate Update at Its 2011 Annual Meeting of Stockholders and Open House

May 23, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., May 23, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a general corporate update in conjunction with its 2011 Annual Meeting of Stockholders and Open House on Thursday, June 16 at...

Recalled DePuy ASR Hip Implant Lawsuits Filed By John David Hart

May 20, 2011 8:39 am | by Bio-Medicine.Org | News | Comments

FORT WORTH, Texas, May 20, 2011 /- Eight cases were filed yesterday by the Law Offices of John David Hart on behalf of plaintiffs whose DePuy ASR Acetabular Hip Replacement Systems have been recalled.  The cases were filed on behalf of Linda Sue and Richard Hall, Holt and Suzanne...

Multiple Presentations Featuring QNEXA® Data to be Presented at the European Congress on Obesity

May 20, 2011 3:42 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., May 20, 2011 /- VIVUS, Inc. (NASDAQ: VVUS ) today announced that multiple abstracts will be presented at the upcoming European Congress on Obesity meeting to be held May 25 to May 28, 2011, at the ICEC Lutfi Kirdar Convention & Exhibition Center in Istanbul,...

Advertisement

PROMUS Elementâ„¢ Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study

May 20, 2011 1:42 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass. and PARIS, May 20, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced 12-month results from its PLATINUM Small Vessel study, demonstrating excellent safety and effectiveness outcomes for the 2.25 mm PROMUS Element™ Everolimus-Eluting Platinum Chromium...

A Nanotubes Patch to Help Heal the Heart

May 19, 2011 2:35 pm | by Massachusetts Institute of Technology | News | Comments

Researchers create carbon nanotubes that mimic natural tissue and can regenerate heart cells in a dish.

Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise

May 19, 2011 10:43 am | by Bio-Medicine.Org | News | Comments

DEERFIELD, Ill., May 19, 2011 /- Astellas Pharma US, Inc. ("Astellas") recently hired Mark Reisenauer as vice president of sales and marketing, oncology. Reporting directly to Patrick Shea, senior vice president of marketing & sales, Reisenauer will be responsible for all U.S....

Spaulding Clinical Honored at BizTech Conference

May 19, 2011 8:39 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., May 19, 2011 /- Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, LLC proudly receives the 2011 IQ (Innovation Quotient) award sponsored by the Marquette University's Graduate School of Management and BizTimes Media, a magazine...

CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year Finalist

May 19, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

ATLANTA, May 19, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced today that its founder and CEO, Jay Yadav, M.D. , is a finalist for the...

Advertisement

Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay

May 18, 2011 11:46 am | by Bio-Medicine.Org | News | Comments

BERLIN, May 18, 2011 /- Research presented this week at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary...

FluoroPharma Announces Completion of Merger and Fund Raising

May 18, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

BOSTON, May 18, 2011 /- FluoroPharma Medical (OTC.BB: CEWM) announced that it has completed a merger transaction with Commercial E Waste Management (CEWM). Effective as of the closing of the transaction, FluoroPharma became a wholly-owned subsidiary of CEWM. The newly combined, publicly...

PLC Medical Systems Adds Vice President of Clinical Affairs

May 18, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., May 18, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that it has named Susan Papalia, RN, BSN, Vice President of Clinical Affairs.  In her new role, she will be responsible for overseeing and...

CryoLife Announces Completion of Acquisition of Cardiogenesis

May 17, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA, and IRVINE, Calif., May 17, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, today announced that it has successfully completed its acquisition of Cardiogenesis Corporation ("Cardiogenesis"). The...

New CE Marked Prognostic Claim for the VerifyNow P2Y12 Test

May 16, 2011 11:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 17, 2011 /- Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use...

BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions

May 16, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, May 16, 2011 /- BridgePoint Medical, Inc., a Minnesota-based medical device company, has announced that they have received clearance of an expanded indication for the CrossBoss™ Catheter and Stingray™ System from the FDA.  The expanded indication includes the...

Abaxis Receives Presidential "E" Award for Exports

May 16, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., May 16, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company was awarded the Presidential "E" Award for Exports by U.S. Department of Commerce Secretary Gary Locke at the...

Lilly USA, LLC Launches TruAssist for Patients

May 16, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, May 16, 2011 /- Lilly USA has launched www.LillyTruAssist.com and 1-855-LLYTRUE (1-855-559-8783), a website and call center for health care providers and patients to access information about Lilly's patient assistance programs, which help connect patients with the Lilly...

Sensing Brain Pressure without Surgery

May 15, 2011 8:32 pm | by Massachusetts Institute of Technology | News | Comments

A noninvasive technique could monitor concussions, migraines, and other conditions.

InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India

May 12, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

TEL AVIV, Israel, May 12, 2011 /- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard ™ mesh protective stent system, is happy to announce that MGuard is now available in India. MGuard, InspireMD's flagship product is India's first mesh-based...

PLC to Demonstrate RenalGuard® at EuroPCR 2011

May 12, 2011 5:38 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., May 12, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced it will demonstrate its innovative new product, RenalGuard®, at EuroPCR, the annual meeting of the European Association of Percutaneous...

Doctors in Germany Among First to Use New Self-Expanding Clot Removal Device for Ischemic Stroke

May 11, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

RAYNHAM, Mass., May 11, 2011 /- Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE™ SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading